Brian M. Stolz
2014
In 2014, Brian M. Stolz earned a total compensation of $1.2M as Senior Vice President and General Manager at Valeant Pharmaceuticals International, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $699,200 |
|---|---|
| Salary | $453,077 |
| Other | $9,173 |
| Total | $1,161,450 |
Stolz received $699.2K in non-equity incentive plan, accounting for 60% of the total pay in 2014.
Stolz also received $453.1K in salary and $9.2K in other compensation.
Rankings
In 2014, Brian M. Stolz's compensation ranked 6,927th out of 13,032 executives tracked by ExecPay. In other words, Stolz earned more than 46.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,927 out of 13,032 | 47th |
Division Manufacturing | 2,538 out of 4,966 | 49th |
Major group Chemicals And Allied Products | 859 out of 1,686 | 49th |
Industry group Drugs | 678 out of 1,365 | 50th |
Industry Pharmaceutical Preparations | 519 out of 1,043 | 50th |
Source: SEC filing on April 29, 2016.
Stolz's colleagues
We found six more compensation records of executives who worked with Brian M. Stolz at Valeant Pharmaceuticals International in 2014.
2014
Ari Kellen
Valeant Pharmaceuticals International
Group Chairman
2014
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2014
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2014
Pavel Mirovsky
Valeant Pharmaceuticals International
President and General Manager, Europe
2014
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2014
Debora Jorn
Valeant Pharmaceuticals International